ArticleExperimental hematology & oncology2025

All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasone.

Theresa Kaeuferle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.